Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Commercial

M&A Analysis: Volume Shrinks In April But Value Inflated By Big Acquisitions

Medtech M&A activity dipped in April from last month but brought in a number of high-value acquisitions. Highlights included Fresenius, the world's largest dialysis firm, selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15bn to investment firm Summit Partners. 

Deals M & A Commercial


Set Alert for Companies

Latest From Companies

Turkey's Alvimedica Ramps Up Global Expansion In Interventional Cardio

Turkish interventional cardiology solutions firm Alvimedica is set to expand significantly its manufacturing capacity in a bid to further strengthen its position in the global heart stents and valves sectors. The company has ring-fenced around $370m to build a new facility, and its investment will be further supported by incentives from the Turkish government.

Cardiology Companies

PureTech’s Akili Scores $55M Investment For Video-Game Therapies

PureTech Health's subsidiary, Akili Interactive, has scored a $55m investment to bring its video-game therapies for treating cognitive dysfunction closer to commercialization.

Digital Health Financing

Inivata Launches Search For New CEO

Liquid biopsy company Inivata is on the hunt for a new CEO following Michael Stocum's departure.

Appointments Companies
See All

Deals and Financings

Set Alert for Deals

Latest From Deals

Philips Joins AHA, UPMC To Invest In Heart Disease, Stroke Innovation

Philips has teamed up for the first time with the American Heart Association and the University of Pittsburgh Medical Center to set up a $30m venture capital fund that will invest in start-ups that are developing solutions to combat heart disease and stroke.

Cardiology Neurology

Medtech Money Flow: Weekly M&A and VC Deals, May 7-13, 2018

In this weekly feature, Medtech Insight presents a roundup of the previous week's M&A deals and venture financing rounds recorded in our M&A and VC Deal Trackers. This edition presents the transactions announced May 7-13, 2018.

Commercial Deals

Pacts In Medtech, March/April 2018

Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech highlights notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we look at industry pacts that were sealed in March and April 2018.

Pacts in Medtech Deals
See All

Market Access

Set Alert for Market Access

Latest From Market Access

QUOTED. May 7, 2018. Jim Cross.

Electrophysiologists are running into challenges in getting subcutanous ICDs covered by private insurers. See why consultant and former Aetna executive Jim Cross thinks that could change this year based on recently updated guidelines.

Market Access Reimbursement

Experimental Or Established? Clinicians, Insurers Debate S-ICDs

Despite many electrophysiologists' enthusiasm for less-invasive cardiac rhythm management devices, insurers are frequently denying coverage of Boston Scientific's Emblem subcutaneous implantable cardioverter defibrillator (S-ICD) for patients, citing what they argue is a lack of adequate clinical data that shows them to be better than "experimental." Boston Scientific recently sponsored a virtual roundtable of physicians to discuss how new professional society guidelines are influencing prescribing and reimbursement of these devices.

Market Access Reimbursement

Medtech Buyers Care Most About Positive Patient Outcomes, Durability When Assessing Products, Survey Finds

Attributes that best differentiate medical devices in a competitive market are: low risk, those that work well for the task demanded, consistent outcomes, good patient outcomes, and proven and trusted brands, according to a survey by marketing analytics firm Vennli. Device manufacturers must be willing to make changes in marketing messages to stand out from the competition, the firm says.

Market Access Advertising, Marketing & Sales
See All

Market Intelligence

Set Alert for Market Intelligence

Latest From Market Intelligence

Market Intel: Insulin Pumps Dominate $7bn-Plus Global Infusion Devices Market

The global infusion drug delivery market continues to be driven by the rising prevalence of chronic disease and associated obesity, coupled with a growing aging population. Technological advancements such as less invasive pumps, needlestick prevention features and miniaturization have also supported the growing demand, but obstacles such as safety and security issues remain. According to a new report by Meddevicetracker, the global market for infusion pumps and disposables will reach $9.9bn by 2022, a CAGR of 6.4% from 2017. This article takes an in-depth look at the overall infusion pumps market, and dives deeper into the three fastest-growing segments – insulin, enteral and disposable pumps – highlighting the key players and competitive landscape.

Metabolic Market Intelligence

QUOTED. May 15, 2018. Thomas Rodgers.

Liquid biopsy marquee player Grail Inc. has reported results of several proof-of-concept approaches to cancer screening that achieved high specificity, and a handful of smaller-scale cancer-specific tests are already available. See what Thomas Rodgers of Grail investor McKesson Ventures had to say about it here.

Quoted Commercial

Market Intel: Liquid Biopsies For Cancer Screening – Far From Reach Or Close At Hand?

While liquid biopsy is becoming routine for cancer treatment stratification and monitoring, using blood tests to screen for early cancer in asymptomatic people remains a tantalizing target. Some question how practical such a test could be but several companies are already en route - some further down the road than others - to achieve this goal. Illumina spin-out Grail is one of these companies and while it is not alone, in a field where size matters, it may have an advantage. This article delves deeper into how these different technologies work and when they could reach the market.

In Vitro Diagnostics Cancer
See All


Set Alert for Appointments

Latest From Appointments

QUOTED. May 14, 2018. Omar Ishrak.

Company stock will make up the "vast majority" of Mike Weinstein's compensation for being Medtronic's new senior VP of strategy. CEO Omar Ishrak said Medtronic's evolving executive compensation policies are an element of the firm's efforts to improve value to shareholders. See what Ishrak said about it here.

Quoted Appointments

Inivata Launches Search For New CEO

Liquid biopsy company Inivata is on the hunt for a new CEO following Michael Stocum's departure.

Appointments Companies

Medtronic Taps JP Morgan Veteran Mike Weinstein To Help Improve Shareholder Value

Weinstein, who has followed the firm extremely closely from his perch as an analyst, says he is very confident about the opportunities that can be leveraged within Medtronic's business, so much so that he is tying most of his salary to company stock.

Appointments Commercial
See All